Advertisement

Pharmaceutisch Weekblad

, Volume 11, Issue 5, pp 146–150 | Cite as

Histamine receptors in the central nervous system

  • H. Timmerman
Update Articles

Abstract

The role of histamine in brain function is discussed. A brief review is presented on the three types of histamine receptors with regard to their biochemistry and functions, as well as on specific ligands, both agonists and antagonists. It is concluded that several aspects of the pharmacology of histamine in the central nervous system are still a matter of empirism and speculations. The recent publications on the brain-penetrating H2 antagonist zolantidine and the selective H3 agonists and antagonists are expected to contribute to the knowledge of the histaminergic pathways in the brain. Therapeutical areas within the central nervous system are related to behaviour (including wake-sleep), neuroendocrinal processes, the control of muscle activity and cerebral circulation.

Keywords

Agonists Antagonists Biochemistry Central nervous system Ligands Pharmacology Receptors, histamine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Steinbusch HWM, Mulder AH. Immunohistochemical localization of histamine in neurons and mast cells in the rat brain. In: Björklund A, Hökfelt T, Kuhar MJ, eds. Handbook of chemical neuroanatomy. Vol. 3. Classical transmitters and transmitter receptors in the CNS. Amsterdam: Elsevier Science Publishers, 1984: 126–40.Google Scholar
  2. 2.
    Airaksinen MS, Punba P. The histaminergic system in guinea pig central nervous system: an immunocytochemical mapping study using an antiserum against histamine. J Comp Neurol 1988;273:163–86.PubMedGoogle Scholar
  3. 3.
    Watanabe T, Taguchi Y, Shiosaka S, et al. Distribution of the histaminergic neuron system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 1984;295:13–25.PubMedGoogle Scholar
  4. 4.
    Inagaki N, Yamatodani A, Ando-Yamamoto M, Tohyama M, Watanabe T, Wada H. Organization of histaminergic fibers in the rat brain. J Comp Neurol 1988;273:283–300.PubMedGoogle Scholar
  5. 5.
    Schwartz JC, Barbin G, Duchemin AM, et al. Histamine receptors in the brain and their possible functions. In: Ganellin CR, Parsons ME, eds. Pharmacology of histamine receptors. Bristol: Wright PSG, 1982:351–91.Google Scholar
  6. 6.
    Arrang JM, Garbarg M, Lancelot JC, et al. Highly potent and selective ligands for H3-receptors. Nature 1987;327:117–23.PubMedGoogle Scholar
  7. 7.
    Rekker RF. The predictive merits of antihistamine QSAR studies. In: Harms AF, ed. Strategy in drug research. Amsterdam: Elsevier Science Publishers, 1982:315–36. (Pharmacochemistry Library. Vol. 4.)Google Scholar
  8. 8.
    Ganellin CR. Chemistry and structure-activity relationships of drugs acting at histamine receptors. In: Ganellin CR, Parsons ME, eds. Pharmacology of histamine receptors. Bristol: Wright PSG, 1982:10–102.Google Scholar
  9. 9.
    Abdel-Latif AA. Calcium-mobilizing receptors, polyphosphoinositides and the generation of second messengers. Pharmacol Rev 1986;38:227–72.PubMedGoogle Scholar
  10. 10.
    Schwartz JC, Garbarg M, Pollard H. Histaminergic transmission in the brain. In: Mountcastle VB, Bloom FE, Geiger SR, eds. Handbook of physiology. Section 1. The nervous system. Vol. IV. Intrinsic regulation systems of the brain. Philadelphia: American Physiological Society, 1986:257–316.Google Scholar
  11. 11.
    Bouthenet ML, Ruat M, Sales N, Garbarg M, Schwartz JC. A detailed mapping of histamine H1-receptors in guinea-pig central nervous system established by autoradiography with [125I]iodobolpyramine. Neuroscience 1988;26:553–600.PubMedGoogle Scholar
  12. 12.
    Fukuda H, Maeyama K, Ito Y, Watanabe T, Wada H. Long-term depletion of histamine in guinea-pigs by administration ofα-fluoromethylhistidine, a specific inhibitor of histidine decarboxylase; effect on the sensitivity of histamine receptors. Agent Actions 1988; 24:55–64.Google Scholar
  13. 13.
    Ruat M, Körner M, Garbarg M, et al. Characterization of histamine H1-receptor binding peptides in guinea-pig brain using [125I]iodoazidophenpyramine, an irreversible specific photoaffinity probe. Proc Natl Acad Sci USA1988;85:2743–7.PubMedGoogle Scholar
  14. 14.
    Chatenoud L, Villemain F, Hoebeke J, et al. Polyclonal and monoclonal antibodies directed against SK&F 94461, a specific H1 histamine receptor ligand. Mol Pharmacol1988;34:136–44.PubMedGoogle Scholar
  15. 15.
    Topiol S, Weinstain H, Osman R. A theoretical investigation of histamine tautomerism. J Med Chem 1984;27: 1531–4.PubMedGoogle Scholar
  16. 16.
    Haaksma EEJ, Donné-Op den Kelder G, Ravenek W, Vernooijs P, Timmerman H. Comparison of the interaction of the histamine H2-agonists histamine and dimaprit: Computer-assisted modeling of receptorligand interactions. In: Golombek A, ed. Theoretical aspects and applications to drug design (in press).Google Scholar
  17. 17.
    Puurunen J. Centrally applied histamine increases gastric acid secretion in rats. Naunyn-Schmiedebergs Arch Pharmacol 1988;338:96–8.PubMedGoogle Scholar
  18. 18.
    Kanof PD, Greengard P. Brain histamine receptors as targets for antidepressant drugs. Nature 1978;272: 329–33.PubMedGoogle Scholar
  19. 19.
    Kanof PD, Greengard P. Pharmacological properties of histamine-sensitive adenylate cyclase from mammalian brain. J Pharm Exp Ther 1979;209:87–96.Google Scholar
  20. 20.
    Hall H, Ögren SO. Effects of antidepressant drugs on histamine-H1 receptors in the brain. Life Sci 1984; 34:597–605.PubMedGoogle Scholar
  21. 21.
    Gogas KR, Hough LB. Effects of zolantidine a brain penetrating H2-receptor antagonist, on naloxone sensitive and naloxone-resistant analgesia. Neuropharmacology 1988;27:357–62.PubMedGoogle Scholar
  22. 22.
    Knigge U, Matzen S, Warberg J. Effects of H2-receptor antagonists on prolactin secretion: specificity and mediation of the response. Acta Endocrinol 1987;115: 461–8.PubMedGoogle Scholar
  23. 23.
    Calcutt CR, Ganellin CR, Griffiths R, et al. Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist. Br J Pharmacol 1988;93:69–78.PubMedGoogle Scholar
  24. 24.
    Sterk GJ, Van der Schaar MWG, Rademaker B, Van der Goot H, Timmerman H. Histamine H2-binding on guinea pig cerebral cortex. Agents Actions 1986; 18:231–4.PubMedGoogle Scholar
  25. 25.
    Arrang JM, Garbarg M, Schwartz JC. Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983;302:832–7.PubMedGoogle Scholar
  26. 26.
    Van der Werf JF, Bast A, Bijloo GJ, Van der Vliet A, Timmerman H. HA autoreceptor assay with superfused slices of rat brain cortex and electrical stimulation. Eur J Pharmacol 1987;138:199–206.PubMedGoogle Scholar
  27. 27.
    Arrang JM, Deveaux B, Chodkiewicz JP, Schwartz JC. H3-receptor control histamine release in human brain. J Neurochem 1988;51:105–8.PubMedGoogle Scholar
  28. 28.
    Arrang JM, Garbarg M, Quach TT, Tuong MDT, Jeramian E, Schwartz JC. Action of betahistine and histamine receptors in the brain. Eur J Pharmacol 1985;111:73–84.PubMedGoogle Scholar
  29. 29.
    Trzeciakowski JP. Inhibition of guinea pig-ileum contractions mediated by a class of histamine receptor resembling the H3 subtype. J Pharmacol Exp Ther 1987;243:874–80.PubMedGoogle Scholar
  30. 30.
    Ishikawa S, Sperilakis N. A novel class (H3) of histamine receptors on perivascular nerve terminals. Nature 1987;327:158–60.PubMedGoogle Scholar
  31. 31.
    Timmerman H. The histamine H3-receptor; its function and ligands. In: Van der Goot H, Pallos L, Timmerman H, eds. Trends in medicinal chemistry '88. Amsterdam: Elsevier Science Publishers, 1989:351–63. (Pharmacochemistry Library. Vol. 12.)Google Scholar
  32. 32.
    White JM, Rumbold GR. Behavioural effects of histamine and its antagonists: a review. Psychopharmacology 1988;95:1–14.PubMedGoogle Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1989

Authors and Affiliations

  • H. Timmerman
    • 1
  1. 1.Department of Pharmacochemistry, Faculty of ChemistryFree UniversityHV Amsterdamthe Netherlands

Personalised recommendations